Omerna

Omerna Biosolutions develops targeted, non-GMO, and non-toxic anti-fungal crop protection solutions based on double-stranded RNA (dsRNA) technology. By leveraging natural RNA interference (RNAi) mechanisms, the company's platform utilizes a protective carrier system to enable controlled, slow release of its active agents. This technology is designed to inhibit pathogenic fungi responsible for significant pre- and post-harvest crop losses, providing a sustainable alternative or complement to traditional chemical fungicides.

The company's solutions aim to address the global challenge of crop loss and the limitations of legacy chemical fungicides, such as pathogen resistance, environmental concerns, and increasing regulatory restrictions. By offering a targeted approach with a short development turnaround time, Omerna supports both field applications and shelf-life extension across a wide range of hosts. Founded in 2023 and supported by the InNegev technological incubator and the Israeli Innovation Authority, the company works with leading academic partners to improve agricultural efficacy while reducing residue levels.